Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cue Biopharma, Inc.(CUE) | 52,928 | 52,928 | 0 | $1.67M | $1.37M | 7.93% | -$301.2K |
| Praxis Precision Medicines, Inc.(PRAX) | 4,450 | 4,450 | 0 | $1.49M | $1.30M | 7.51% | -$193.8K |
| Royalty Pharma plcCL A(RPRX) | 21,400 | 21,400 | 0 | $1.20M | $1.25M | 7.24% | +$49.0K |
| Fennec Pharmaceuticals Inc.(FENC) | 112,434 | 112,434 | 0 | $1.21M | $1.20M | 6.94% | -$11.2K |
| COMPASS Pathways plcADS(CMPS) | 80,000 | 80,000 | 0 | $1.13M | $995.2K | 5.77% | -$136.8K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 67,500 | 67,500 | 0 | $1.31M | $789.8K | 4.58% | -$524.5K |
| Geron Corporation(GERN) | 578,000 | 578,000 | 0 | $739.8K | $710.9K | 4.12% | -$28.9K |
| Milestone Pharmaceuticals Inc.(MIST) | 820,000 | 820,000 | 0 | $1.10M | $709.9K | 4.11% | -$388.9K |
| Biohaven Ltd.(BHVN) | 51,700 | 51,700 | 0 | $769.3K | $690.2K | 4.00% | -$79.1K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 36,000 | 36,000 | 0 | $787.0K | $676.8K | 3.92% | -$110.2K |
| Benitec Biopharma Inc.(BNTC) | 62,000 | 62,000 | 0 | $829.6K | $620.0K | 3.59% | -$209.6K |
| Disc Medicine, Inc.(IRON) | 8,100 | 8,100 | 0 | $592.4K | $530.2K | 3.07% | -$62.2K |
| Sarepta Therapeutics, Inc.(SRPT) | 28,500 | 28,500 | 0 | $512.1K | $519.3K | 3.01% | +$7.1K |
| Kura Oncology, Inc.(KURA) | 46,000 | 46,000 | 0 | $504.6K | $492.7K | 2.85% | -$12.0K |
| Viatris Inc.(VTRS) | 27,700 | 27,700 | 0 | $439.9K | $490.8K | 2.84% | +$51.0K |
| Ardelyx Inc | 128,650 | 128,650 | 0 | $656.1K | $440.0K | 2.55% | -$216.1K |
| Edgewise Therapeutics, Inc.(EWTX) | 9,100 | 9,100 | 0 | $369.7K | $369.5K | 2.14% | -$273 |
| uniQure N.V.SHS(QURE) | 14,700 | 14,700 | 0 | $677.1K | $355.2K | 2.06% | -$321.9K |
| Azenta, Inc.(AZTA) | 9,700 | 9,700 | 0 | $247.5K | $338.4K | 1.96% | +$90.9K |
| Pacira BioSciences, Inc.(PCRX) | 13,500 | 13,500 | 0 | $342.5K | $338.2K | 1.96% | -$4.3K |
| Humacyte, Inc.(HUMA) | 650,000 | 650,000 | 0 | $507.3K | $336.5K | 1.95% | -$170.8K |
| BridgeBio Pharma, Inc.(BBIO) | 5,000 | 5,000 | 0 | $372.4K | $329.0K | 1.91% | -$43.4K |
| Janux Therapeutics, Inc.(JANX) | 19,000 | 19,000 | 0 | $291.8K | $328.3K | 1.90% | +$36.5K |
| Dyne Therapeutics, Inc.(DYN) | 18,000 | 18,000 | 0 | $399.8K | $290.0K | 1.68% | -$109.8K |
| Jasper Therapeutics, Inc.(JSPR) | 465,000 | 465,000 | 0 | $195.8K | $269.7K | 1.56% | +$73.9K |
| Mineralys Therapeutics, Inc.(MLYS) | 10,500 | 10,500 | 0 | $283.3K | $263.9K | 1.53% | -$19.4K |
| GH Research PLC(GHRS) | 10,200 | 10,200 | 0 | $274.2K | $239.5K | 1.39% | -$34.7K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 86,000 | 86,000 | 0 | $294.1K | $226.2K | 1.31% | -$67.9K |
| REGENXBIO Inc.(RGNX) | 26,600 | 26,600 | 0 | $318.7K | $200.3K | 1.16% | -$118.4K |
| Innoviva, Inc.(INVA) | 8,200 | 8,200 | 0 | $186.2K | $173.9K | 1.01% | -$12.3K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 5,250 | 5,250 | 0 | $137.7K | $138.8K | 0.80% | +$1.1K |
| Innate Pharma S.A.ADS(IPHA) | 81,151 | 81,151 | 0 | $149.3K | $132.3K | 0.77% | -$17.0K |
| Seres Therapeutics, Inc.(MCRB) | 31,570 | 31,570 | 0 | $249.1K | $105.8K | 0.61% | -$143.3K |
| Spruce Biosciences Inc | 1,000 | 1,000 | 0 | $54.0K | $48.6K | 0.28% | -$5.4K |
| Lantheus Holdings, Inc.(LNTH) | 5,500 | 0 | -5,500 | $610.2K | $0 | — | -$610.2K |